Skip to main content
رجوع
TECH logo

Bio-Techne Corporation

جودة البيانات: 100%
TECH
NASDAQ Healthcare Biotechnology
KWD 52.00
▲ KWD 0.52 (1.01%)
القيمة السوقية: 8.14B
نطاق اليوم
KWD 51.63 KWD 53.53
نطاق 52 أسبوعًا
KWD 46.01 KWD 72.16
حجم التداول
1,585,744
متوسط 50 يوم / 200 يوم
KWD 60.87 / KWD 57.62
الإغلاق السابق
KWD 51.48

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 110.8 0.4
P/B 4.2 2.9
ROE % 3.7 3.8
Net Margin % 6.0 3.9
Rev Growth 5Y % 7.0 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 69.330 +33.3%
Low: KWD 62.000 High: KWD 79.000
مكرر الربحية المستقبلي
26.2
ربحية السهم المستقبلية
KWD 1.985
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.2 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 3.150
KWD 3.102 – KWD 3.207
1.7 B 1
FY2029 KWD 3.030
KWD 2.984 – KWD 3.085
1.5 B 1
FY2028 KWD 2.519
KWD 2.222 – KWD 2.759
1.4 B 3

النقاط الرئيسية

Revenue grew 6.98% annually over 5 years — modest growth
Earnings declined -56.34% over the past year
ROE of 3.68% is below average
Debt/Equity of 0.23 — conservative balance sheet
Generating 256.55M in free cash flow
P/E of 110.84 — premium valuation

النمو

Revenue Growth (5Y)
6.98%
Revenue (1Y)5.23%
Earnings (1Y)-56.34%
FCF Growth (3Y)8.95%

الجودة

Return on Equity
3.68%
ROIC3.25%
Net Margin6.02%
Op. Margin8.38%

الأمان

Debt / Equity
0.23
Current Ratio3.46
Interest Coverage12.02

التقييم

P/E Ratio
110.84
P/B Ratio4.24
EV/EBITDA82.32
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.23% Revenue Growth (3Y) 3.58%
Earnings Growth (1Y) -56.34% Earnings Growth (3Y) -49.27%
Revenue Growth (5Y) 6.98% Earnings Growth (5Y) -14.97%
Profitability
Revenue (TTM) 1.22B Net Income (TTM) 73.40M
ROE 3.68% ROA 2.87%
Gross Margin 64.80% Operating Margin 8.38%
Net Margin 6.02% Free Cash Flow (TTM) 256.55M
ROIC 3.25% FCF Growth (3Y) 8.95%
Safety
Debt / Equity 0.23 Current Ratio 3.46
Interest Coverage 12.02 Dividend Yield 0.01%
Valuation
P/E Ratio 110.84 P/B Ratio 4.24
P/S Ratio 6.67 PEG Ratio -1.97
EV/EBITDA 82.32 Dividend Yield 0.01%
Market Cap 8.14B Enterprise Value 8.42B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.22B 1.16B 1.14B 1.11B 931.03M
Net Income 73.40M 168.11M 285.26M 272.05M 140.41M
EPS (Diluted) 0.46 1.05 1.76 1.66 0.87
Gross Profit 790.27M 769.73M 769.82M 756.50M 632.85M
Operating Income 102.26M 206.69M 298.94M 296.59M 237.30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.56B 2.70B 2.64B 2.29B 2.26B
Total Liabilities 639.06M 635.02M 672.18M 593.79M 691.72M
Shareholders' Equity 1.92B 2.07B 1.97B 1.70B 1.56B
Total Debt 444.06M 419.54M 454.97M 325.97M 420.55M
Cash & Equivalents 162.19M 151.79M 180.57M 172.57M 199.09M
Current Assets 608.30M 617.42M 621.48M 605.56M 510.61M
Current Liabilities 175.85M 159.38M 128.51M 176.02M 152.28M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#860 of 1024
28

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026